SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
There's a NBC Nightly News special tonight on the "common cold"....

msnbc.com

..... and some on the Agouron thread are making noise about it. Should be interesting, and I believe that few know of VPHM's efforts with picornaviruses......

Monday on NBC ‘Nightly News'
Why does the common cold affect so many at this
time of year? Will there ever be a cure? Find out about
new drugs that could someday provide real treatment,
or even prevent the common cold before it strikes.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2557Today, the U.S. Food and Drug Administration approved Livtencity (maribavir) as scaram(o)uche111/23/2021
2556Piece of cake....... businesswire.com "FDA Advisory Committee Recommends scaram(o)uche110/21/2021
2555Antiviral Res. 2018 Oct;158:255-263. doi: 10.1016/j.antiviral.2018.08.015. Epub scaram(o)uche-9/25/2018
2554scielo.cl :-)scaram(o)uche19/8/2016
2553what Dr. Nitz is doing these days (DFH Pharma??)....... Sci Rep. 2016 Jun 6;6:2scaram(o)uche16/9/2016
2552ncbi.nlm.nih.gov "pleconaril" and "suggests" in same abstrascaram(o)uche112/31/2015
2551Shire probably munched vphm for the cure to the common cold. Phoenix! (Congratscaram(o)uche-11/11/2013
2550VPHM popping with some volume but I don't see news yet.sjemmeri-6/17/2013
2549no relevance to today's company...... Transplant Proc. 2013 May;45(4):1603-scaram(o)uche-6/4/2013
2548Am J Transplant. 2012 Sep 4. doi: 10.1111/j.1600-6143.2012.04231.x. [Epub ahead scaram(o)uche-10/30/2012
2547Hey Fred – good job. This was one of my bigger mistakes a few years back. I was Robohogs-5/1/2012
2546Yeah!fred hayes25/1/2012
2545Well my calculations were off. On the CC they say that the target of $600M was IRWIN JAMES FRANKEL-5/1/2012
2544>> Cost of sales increased over the three month period in the prior year bIRWIN JAMES FRANKEL-5/1/2012
2543Cum Cinryze $594.9M. :-( Well - by next Q it is a SLAM DUNK. :-) ijIRWIN JAMES FRANKEL-5/1/2012
2542ViroPharma Incorporated Reports First Quarter 2012 Financial Results [graphic]PrIRWIN JAMES FRANKEL15/1/2012
2541>> Thinking maybe this is it for the VPHM drop and adding some now. That IRWIN JAMES FRANKEL-4/16/2012
2540Thinking maybe this is it for the VPHM drop and adding some now.sjemmeri-4/16/2012
2539The study looks good. I would think subQ would be favored over IV by the patienIRWIN JAMES FRANKEL13/6/2012
2538ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1IRWIN JAMES FRANKEL-3/6/2012
2537Cinryze®? (C1 Inhibitor [Human]) Now Available in the UK for Routine PrevenIRWIN JAMES FRANKEL-2/29/2012
2536...until the following quarter. But what's a few months among friends? Andfred hayes-2/28/2012
2535Well unless VPHM does significantly more (~$74m) than the $66.7M of Cinryze saleIRWIN JAMES FRANKEL-2/28/2012
2534ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial ResuIRWIN JAMES FRANKEL-2/28/2012
2533>> are we going to get our CVR pay-out this month? I doubt it. My guess IRWIN JAMES FRANKEL-2/14/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News